Enhanced anticancer activity of encapsulated geraniol into biocompatible lipid nanoparticles against A549 human lung cancer cells

[1]  N. Girard,et al.  Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer. , 2022, The New England journal of medicine.

[2]  G. Rath,et al.  Nanotherapeutics approaches to overcome P-glycoprotein-mediated multi-drug resistance in cancer. , 2021, Nanomedicine : nanotechnology, biology, and medicine.

[3]  H. Maeng,et al.  Pharmaceutical Formulations with P-Glycoprotein Inhibitory Effect as Promising Approaches for Enhancing Oral Drug Absorption and Bioavailability , 2021, Pharmaceutics.

[4]  J. Ferlay,et al.  Cancer statistics for the year 2020: An overview , 2021, International journal of cancer.

[5]  N. Durán,et al.  Design of magnetic hybrid nanostructured lipid carriers containing 1,8-cineole as delivery systems for anticancer drugs: Physicochemical and cytotoxic studies. , 2021, Colloids and surfaces. B, Biointerfaces.

[6]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[7]  D. Carbone,et al.  First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial. , 2021, The Lancet. Oncology.

[8]  G. Islan,et al.  Binary medical nanofluids by combination of polymeric Eudragit nanoparticles for vehiculization of Tobramycin and Resveratrol: antimicrobial, hemotoxicity and protein corona studies. , 2021, Journal of pharmaceutical sciences.

[9]  Jin-jian Lu,et al.  Natural Products in Cancer Therapy: Past, Present and Future , 2021, Natural Products and Bioprospecting.

[10]  Nicholas A. Peppas,et al.  Engineering precision nanoparticles for drug delivery , 2020, Nature reviews. Drug discovery.

[11]  N. Durán,et al.  Assessment of in vitro cytotoxicity of imidazole ionic liquids and inclusion in targeted drug carriers containing violacein , 2020, RSC advances.

[12]  Wanda Mączka,et al.  One Hundred Faces of Geraniol , 2020, Molecules.

[13]  Gregory Marslin,et al.  Cordycepin Nanoencapsulated in Poly(Lactic-Co-Glycolic Acid) Exhibits Better Cytotoxicity and Lower Hemotoxicity Than Free Drug , 2020, Nanotechnology, science and applications.

[14]  Jeferson S. Santos,et al.  Carvacrol loaded nanostructured lipid carriers as a promising parenteral formulation for leishmaniasis treatment. , 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[15]  David J Newman,et al.  Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. , 2020, Journal of natural products.

[16]  S. Lavarías,et al.  Induction of oxidative stress as a possible mechanism by which geraniol affects the proliferation of human A549 and HepG2 tumor cells. , 2020, Chemico-biological interactions.

[17]  Karsten Mäder,et al.  Solid lipid nanoparticles , 2012 .

[18]  A. Talevi,et al.  Hybrid Ofloxacin/eugenol co-loaded solid lipid nanoparticles with enhanced and targetable antimicrobial properties. , 2019, International journal of pharmaceutics.

[19]  J. Prados,et al.  Lipid-Based Nanoparticles: Application and Recent Advances in Cancer Treatment , 2019, Nanomaterials.

[20]  D. Karthikeyan,et al.  Development and Characterization of Metformin Loaded Pectin Nanoparticles for T2 Diabetes Mellitus. , 2019, Pharmaceutical nanotechnology.

[21]  Jan Sundquist,et al.  Clinical landscape of cancer metastases , 2018, Cancer medicine.

[22]  M. Truong,et al.  Targeted Therapy and Immunotherapy in the Treatment of Non-Small Cell Lung Cancer. , 2018, Radiologic clinics of North America.

[23]  N. Durán,et al.  Development and tailoring of hybrid lipid nanocarriers. , 2018, Current pharmaceutical design.

[24]  N. Durán,et al.  Design, characterization and in vitro evaluation of linalool-loaded solid lipid nanoparticles as potent tool in cancer therapy. , 2017, Colloids and surfaces. B, Biointerfaces.

[25]  S. Ghanbarzadeh,et al.  Formulation of Menthol-Loaded Nanostructured Lipid Carriers to Enhance Its Antimicrobial Activity for Food Preservation , 2017, Advanced pharmaceutical bulletin.

[26]  R. Shukla,et al.  Gold Nanoparticle Biodistribution and Toxicity: Role of Biological Corona in Relation with Nanoparticle Characteristics , 2017 .

[27]  E. C. Naylor,et al.  Targeted Therapy and Immunotherapy for Lung Cancer. , 2016, Surgical oncology clinics of North America.

[28]  I. So,et al.  The antitumor effects of geraniol: Modulation of cancer hallmark pathways (Review) , 2016, International journal of oncology.

[29]  Qiang Zhang,et al.  Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[30]  G. Caracciolo,et al.  The biomolecular corona of nanoparticles in circulating biological media. , 2015, Nanoscale.

[31]  D. P. de Sousa,et al.  Antitumor Activity of Monoterpenes Found in Essential Oils , 2014, TheScientificWorldJournal.

[32]  M. Polo,et al.  Suppression by Geraniol of the Growth of A549 Human Lung Adenocarcinoma Cells and Inhibition of the Mevalonate Pathway in Culture and In Vivo: Potential Use in Cancer Chemotherapy , 2014, Nutrition and cancer.

[33]  Ji-Ho Park,et al.  Endocytosis and exocytosis of nanoparticles in mammalian cells , 2014, International journal of nanomedicine.

[34]  A. Silva,et al.  Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - a systematic review of in vitro data. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[35]  F. Stintzing,et al.  Stability of Essential Oils: A Review , 2013 .

[36]  Warren C W Chan,et al.  The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.

[37]  E. Souto,et al.  Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway. , 2012, International journal of pharmaceutics.

[38]  Matthew P. Jacobson,et al.  Dysregulated pH: a perfect storm for cancer progression , 2011, Nature Reviews Cancer.

[39]  R. Müller,et al.  Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure. , 2011, International journal of pharmaceutics.

[40]  Shiladitya Sengupta,et al.  Nanoparticles in cancer chemotherapy. , 2011, Progress in molecular biology and translational science.

[41]  Weiyang Chen,et al.  Geraniol — A review of a commercially important fragrance material , 2010 .

[42]  L. Galluzzi,et al.  Targeting mitochondria for cancer therapy , 2010, Nature Reviews Drug Discovery.

[43]  M. J. Santander-Ortega,et al.  Colloidal stability of pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms. , 2006, Journal of colloid and interface science.

[44]  S. Funari,et al.  Scattering curves of ordered mesoscopic materials. , 2005, The journal of physical chemistry. B.

[45]  T C Fisher,et al.  The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation. , 2004, Biophysical journal.

[46]  Kiyotaka Sato.  Crystallization behaviour of fats and lipids — a review , 2001 .

[47]  M. Veit,et al.  Bioavailability and pharmacokinetics of natural volatile terpenes in animals and humans. , 2000, Planta medica.

[48]  A. Thünemann,et al.  Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. , 2000, International journal of pharmaceutics.

[49]  S. Simões,et al.  Steric stabilization of nanoparticles: Size and surface properties , 1996 .